Mayo Clinic Laboratory and pathology research roundup: April 4
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.
We report the utility of rapid antigen tests (RAgT) in a cohort of US healthcare personnel with COVID-19 infection who met symptom criteria to return to work at day 5 or later of isolation. 11.9% of initial RAgT were negative. RAgT can be helpful to guide return to work decisions.
Published to PubMed This Week
- Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Lancet - Rio de Janeiro Global Consensus on Landmarks, Definitions and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study.
Gastroenterology - Understanding T-cell responses to COVID-19 is essential for informing public health strategies.
Science Immunology - Hematopoietic Stem Cell Transplant-Membranous Nephropathy is Associated with Protocadherin FAT1.
Journal of the American Society of Nephrology - Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
Genetics in Medicine - Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar.
Journal of Clinical Immunology - COVID-19-associated cardiac pathology at post-mortem evaluation: A Collaborative systematic Review.
Clinical of Microbiology and Infection - Updating Normal Organ Weights Using a Large Current Sample Database.
Archives of Pathology & Laboratory Medicine - Sex disparities in management and outcomes of cardiac arrest complicating acute myocardial infarction in the United States.
Resuscitation - Type 1, Type 2 myocardial infarction and non-ischemic myocardial injury-opinion from the front lines.
American Journal of Medicine
